Inovio Pharmaceuticals
INO
#9510
Rank
HK$0.70 B
Marketcap
HK$8.62
Share price
-1.79%
Change (1 day)
-42.09%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.56. In 2024 the company made an earnings per share (EPS) of -HK$30.95 an increase over its 2023 EPS that were of -HK$47.71.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.47%
2024-HK$30.95-35.14%
2023-HK$47.71-56.62%
2022-HK$109.99-19.54%
2021-HK$136.7135.9%
2020-HK$100.59-11.57%
2019-HK$113.7515.24%
2018-HK$98.71-2.78%
2017-HK$101.536.93%
2016-HK$94.95134.88%
2015-HK$40.42-29.51%
2014-HK$57.35-57.34%
2013-HK$134.44146.55%
2012-HK$54.5320.83%
2011-HK$45.13-29.41%
2010-HK$63.93-48.48%
2009-HK$124.1010%
2008-HK$112.8111.11%
2007-HK$101.53-41.3%
2006-HK$172.98-66.91%
2005-HK$522.70110.61%
2004-HK$248.19-61.63%
2003-HK$646.80186.67%
2002-HK$225.63
2001N/A-100%
2000-HK$180.50-63.64%
1999-HK$496.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.26-486.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.41-350.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.66-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.27-353.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.52-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
HK$2.74-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA